Methamphetamine (meth) is a powerful and highly addictive synthetic stimulant. Psychotic symptoms such as hallucinations, delusions, and paranoia with its related violence, are experienced by up to 40% of regular meth users.
Meth is more affordable and potent than ever before due to the recent increase in industrial-scale production. Meth use has surged, driving a rise in drug-induced psychosis cases and straining mental health systems.
Meth at the Center of the Overdose Epidemic’s Fourth Wave
This is a key factor in the ongoing U.S. overdose epidemic’s fourth wave, involving both opioids and stimulants like meth. Meth-related deaths in the US rose more than 61-fold between 1999 and 2021 [1].
Drug-induced psychosis is a severe mental disruption that not only causes immediate harm but can also trigger long-term psychiatric disorders. And it places an immense burden on individuals, families, and healthcare systems.
In this article, I look into this epidemic and discuss what causes meth-induced psychosis, diagnostic challenges, the rising trend and risk factors, as well as treatment.
What is Methamphetamine-Induced Psychosis?
Methamphetamine-induced psychosis (MIP) is a severe mental state triggered by meth use. It can occur during intoxication, withdrawal, or as a result of chronic use. The hallmark symptoms closely mimic those of paranoid schizophrenia. These include [2]:
- Hallucinations: Primarily auditory (hearing voices) and tactile (sensation of insects crawling on the skin).
- Delusions: Common delusions include intense paranoia, persecutory delusions (belief that one is being followed or plotted against), and grandiose beliefs about one’s own importance.
- Thought Disorders: Disorganized thinking and speech.
The Neurobiology: How Meth Hijacks the Brain
Meth floods the brain with dopamine by inhibiting its reuptake and storage. This surge initially causes euphoria but eventually leads to damage in the brain’s reward and cognitive centers.
More complex, long-term damage follows. Chronic meth use increases glutamate, an excitatory neurotransmitter, which can become toxic. This excess glutamate damages crucial GABAergic interneurons in the cortex, which are responsible for filtering and fine-tuning brain signals.
This damage is believed to be the core mechanism behind the disorganized thought and psychosis.
The Clinical Picture and Diagnostic Challenge
A substantial percentage of regular meth users—from 36.5% to 60% of those with meth use disorder—will experience psychosis. Regular meth users are 11 times more likely to experience psychosis than the general population, with psychosis reaching a peak likelihood of 48% following 16 days or more of chronic use [2].
This presents a critical challenge for clinicians: the positive symptoms of meth-induced psychosis (hallucinations and delusions) are clinically indistinguishable from those of primary psychotic disorders like schizophrenia. A recent study confirmed there is no significant difference in positive symptoms between the two groups.
Individuals with meth-induced psychosis often initially present with fewer “negative symptoms” (social withdrawal, apathy, and flat affect) compared to those with schizophrenia. However, this distinction can blur over time.
From Temporary State to Chronic Illness
Meth psychosis symptoms typically subside once the user has stopped taking the drug. However, for some, a prolonged psychosis persists even after the drug has cleared from the body, with the majority of psychotic symptoms resolving within 1 month [2].
For others, psychotic symptoms can persist for months after stopping meth use.
Critically, a significant proportion of individuals initially diagnosed with psychosis will later be diagnosed with a chronic condition such as schizophrenia. Studies show this transition occurs in up to 10-38% of cases.
The Link to Schizophrenia
In a Japanese study, where there is a long history of meth abuse, 28% of meth users continued to display “schizophrenia-like symptoms” 8–12 years following abstinence [3].
Meth may unmask an underlying vulnerability to mental illness. Individuals with a family history of schizophrenia are significantly more likely to develop persistent psychosis after meth use.
There is uncertainty about whether meth use causes schizophrenia or whether chronic meth psychosis represents a distinct disorder that should be distinguished from other primary psychoses.
Researchers are still working to determine the relationship between acute versus chronic meth-induced psychosis, schizophrenia, and genetic and environmental factors [4].
The Rising Trend of Meth-Induced Psychosis
The prevalence of psychosis (40% of users) noted above is shocking [5]. Risk is increased fivefold by chronic or high-dose use, with symptoms peaking after 16+ days of use.
Meth-involved psychiatric hospitalizations rose 68% from late 2015 to 2019, outpacing other substance-related cases. US overdose deaths involving meth climbed from 547 in 1999 to 34,855 by 2023, with sharp regional spikes in the US Southeast and West [1].
Emergency visits for meth-related psychosis have increased dramatically, often comprising 50% of short-stay psychiatric admissions in some areas.
The Risk Factors of Psychosis
Dependent users face 3 to 11 times higher psychosis odds than non-dependent ones or the general population. Highly increased prevalence of psychotic illness is associated with use of high-potency crystal meth in people who inject drugs, particularly where there is dependent use [6].
Risk is much greater with crystal meth use, especially with co-use of fentanyl, which masks overdose signs. Some cases persist beyond 6 months, transitioning to schizophrenia-like disorders in 5% to 39% of patients.
The Public Health Impact
This crisis burdens ERs, where meth psychosis accounts for up to 10% of admissions in some facilities. The growing trend of polysubstance use amplifies harms and contributes to 59% of stimulant-involved overdoses. Interventions such as contingency management and harm reduction are essential for treatment.
In 2022, a new plan was approved by the White House Office of National Drug Control Policy designed to reduce methamphetamine supply, trafficking, use, and overdoses [7].
The Colorado Meth Project is a large-scale prevention program aimed at reducing meth use through public service messaging, public policy, and community outreach. MethProject.org is a definitive source for information about meth for teens—supported by extensive media campaigns that communicate the risks of meth use.
Treatment
There are two approaches currently in use:
- Acute Care: In emergency settings, benzodiazepines are used for agitation, and antipsychotics may be prescribed to manage acute psychotic symptoms.
- Long-term Management: This psychosis often requires management in an inpatient psychiatric or other crisis intervention setting. Long-term treatment focuses on abstinence from meth, therapy, and sometimes continued antipsychotic medication for those with persistent symptoms. Treatment for meth use disorder itself often relies on behavioral therapies like Contingency Management.
Find Supportive Care at Red Rock Recovery
Substance use disorder, or addiction, can feel insurmountable, but Red Rock Recovery Center is here to help you begin your recovery journey today with our core values of Community, Connection, and Purpose and a trauma-informed approach.
Red Rock Recovery Center stands out from most drug and alcohol rehab centers in Colorado by offering a full continuum of care approach to substance use disorder (SUD) and addiction treatment.
Our Colorado rehab center is proud to offer an addiction treatment program that includes all necessary steps to healing, from medical detox to aftercare services. Located close to major cities such as Colorado Springs, we are uniquely equipped to help countless families find healing.
Sources
[1] University of Mississippi. nd. Methamphetamine Deaths Have Risen Across Every U.S. Region.
[2] Wearne TA and Cornish JL (2018) A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology. Front. Psychiatry 9:491.
[3] Teraoka A. Prognostic and criminological studies on the mental disorder caused by the chronic methamphetamine intoxication. Seishin Shinkeigaku Zasshi. 1967 Jun;69(6):597-619. Japanese.
[4] Camfield K, et al. 2024. BEAT Meth MIPD Expert Panel. Diagnosis of methamphetamine-induced psychotic disorder: Findings of an expert consensus panel. Early Interv Psychiatry. 2024 Dec;18(12):1015-1021.
[5] Glasner-Edwards, S., & Mooney, L. J. (2014). Methamphetamine psychosis: epidemiology and management. CNS drugs, 28(12), 1115–1126.
[6] Lappin J., et al. 2016. Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population. Int J Drug Policy. 2016 Dec;38:16-20.
[7] Representative Josh Harder. 2022. After Harder’s Push, White House Releases New Plan to Fight Methamphetamine.